Coordinate action of membrane-type matrix metalloproteinase-1 (MT1-MMP) and MMP-2 enhances pericellular proteolysis and invasion

Cancer Science

Volumn 101, Issue 4, 2010, Pages 843-847

  Sato, Hiroshi ^a   Takino, Takahisa ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; GELATIN; GELATINASE A; MATRIX METALLOPROTEINASE 14; TETRASPANIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; COLLAGEN; INTERSTITIAL COLLAGENASE;

CANCER INVASION; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL GROWTH; CELL INVASION; CELLULAR DISTRIBUTION; DENATURATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME LOCALIZATION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; REVIEW; TUMOR GROWTH; ANIMAL; ENZYMOLOGY; EXTRACELLULAR MATRIX; HYDROLYSIS; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; COLLAGEN; COLLAGEN TYPE I; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMANS; HYDROLYSIS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 77957281923     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01498.x     Document Type: Review

References (52)

1. Birkedal HH, Moore WG, Bodden MK et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197-250.
2. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-73.
3. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990; 6: 121-5.
4. Curry TJ, Mann JS, Estes RS, Jones PB. Alpha 2-macroglobulin and tissue inhibitor of metalloproteinases: collagenase inhibitors in human preovulatory ovaries. Endocrinology, 1990; 127: 63-8.
5. Zhu C, Woessner JJ. A tissue inhibitor of metalloproteinases and α-macroglobulins in the ovulating rat ovary: possible regulators of collagen matrix breakdown. Biol Reprod 1991; 45: 334-42.
6. Brown PD, Bloxidge RE, Stuart NSA, Gatter KC, Carmichael J. Association between expression of activated 72-Kilodaloton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 1993; 85: 574-8.
7. Azzam HS, Arand G, Lippman ME, Thompson EW. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 activation. J Natl Cancer Inst 1993; 85: 1758-64.
8. Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61-5.
9. Sato H, Takino T, Miyamori H. Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis. Cancer Sci 2005; 96: 212-7.
10. Itoh Y. MT1-MMP: A Key Regulator of Cell Migration in Tissue. IUBMB Life 2006; 58: 589-96.
11. Will H, Hinzmann B. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 1995; 231: 602-8.
12. Takino T, Sato H, Shinagawa A, Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J Biol Chem 1995; 270: 23013-20.
13. Velasco G, Cal S, Merlos-Suarez A et al. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Cancer Res 2000; 60: 877-82.
14. Miyamori H, Takino T, Kobayashi Y et al. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J Biol Chem 2001; 276: 28204-11.
15. Sato H, Kinoshita T, Takino T et al. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 1996; 393: 101-4.
16. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 1996; 271: 17119-23.
17. Bigg HF, Morrison CJ, Butler GS et al. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res 2001; 61: 3610-8.
18. Kolkenbrock H, Essers L, Ulbrich N, Will H. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase. Biol Chem 1999; 380: 1103-8.
19. Hernandez-Barrantes S, Toth M, Bernardo MM et al. Binding of active (57kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and Pro-MMP-2 activation. J Biol Chem 2000; 275: 12080-9.
20. Toth M, Bernardo MM, Gervasi DC et al. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. J Biol Chem 2000; 275: 41415-23.
21. Holmbeck K, Bianco P, Caterina J et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999; 99: 81-92.
22. Zhou Z, Apte SS, Soininen R et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A 2000; 97: 4052-7.
23. Itoh T, Tanioka M, Yoshid H, Yoshioka T, Nishimoto H, Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998; 58: 1048-51.
24. Martignetti JA, Al Aqeel AA, Al Sewairi W et al. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 2001; 28: 261-5.
25. Vu TH. Don't mess with the matrix. Nat Genet 2001; 28: 202-3.
26. Oh J, Takahashi R, Adachi E et al. Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice. Oncogene 2004; 23: 5041-8.
27. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463-516.
28. Okada Y. Proteinases and matrix degradation. In: Ruddy S, Harris ED Jr, Sledg CB, eds. Kelley's Textbook of Rheumatology. Philadelphia, PA, USA: W.B. Saunders Company, 2001; 55-72.
29. Hayashidani S, Tsutsui H, Ikeuchi M et al. Targeted deletion of matrix metalloproteinase-2 attenuates early left ventricular rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 2003; 285: H1229-35.
30. Heymans S, Luttun A, Nuyens D et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999; 5: 1135-42.
31. Ueno H, Nakamura H, Inoue M et al. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinoma. Cancer Res 1997; 57: 2055-60.
32. Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y, Seiki M. Activation of the precursor of gelatinase A/72kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 1995; 64: 355-9.
33. Howard EW, Banda MJ. Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase: Identification of a stabilization site. J Biol Chem 1991; 266: 17972-7.
34. Strongin AY, Collier I, Bannikov G et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995; 270: 5331-8.
35. Kinoshita T, Sato H, Okada A et al. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 1998; 273: 16098-103.
36. Butler GS, Butler MJ, Atkinson SJ et al. The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 1998; 273: 871-80.
37. Zucker S, Drews M, Conner C et al. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 1998; 273: 1216-22.
38. Cao J, Sato H, Takino T, Seiki M. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 1995; 270: 801-5.
39. Atkinson SJ, Crabbe T, Cowell S et al. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 1995; 270: 30479-85.
40. Kudo T, Takino T, Miyamori H et al. Substrate choice of membrane-type 1 matrix metalloproteinase is dictated by tissue inhibitor of metalloproteinase-2 levels. Cancer Sci 2007; 98: 563-8.
41. Nishida Y, Miyamori H, Thompson EW, Takino T, Endo Y, Sato H. Activation of Matrix Metalloproteinase-2 (MMP-2) by Membrane Type-1 Matrix Metalloproteinase through an Artificial Receptor for ProMMP-2 Generates Active MMP-2. Cancer Res 2008; 68: 9096-104.
42. Bernardo MM, Fridman R. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochem J 2003; 374: 739-45.
43. Morrison CJ, Butler GS, Bigg HF et al. Cellular Activation of MMP-2 (Gelatinase A) by MT2-MMP Occurs via a TIMP-2-independent Pathway. J Biol Chem 2001; 276: 47402-10.
44. Morrison CJ, Overall CM. TIMP Independence of Matrix Metalloproteinase (MMP)-2 Activation by Membrane Type 2 (MT2)-MMP Is Determined by Contributions of Both the MT2-MMP Catalytic and Hemopexin C Domains. J Biol Chem 2006; 281: 26528-39.
45. Takino T, Miyamori H, Watanabe Y et al. Membrane type 1 matrix metalloproteinase regulates collagendependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration. Cancer Res 2004; 64: 1044-9.
46. Takino T, Saeki H, Miyamori H et al. Inhibition of membrane-type 1 matrix metalloproteinase at cellmatrix adhesions. Cancer Res 2007; 67: 11621-9.
47. Kenny HA, Kaur S, Coussens LM, Lengyel E. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 2008; 118: 1367-79.
48. Yañez-Mó M, Barreiro O, Gonzalo P et al. MT1-MMP collagenolytic activity is regulated through association with tetraspanin CD151 in primary endothelial cells. Blood 2008; 112: 3217-26.
49. Lafleur MA, Xu D, Hemler ME. Tetraspanin Proteins Regulate Membrane Type-1 Matrix Metalloproteinase-dependent Pericellular Proteolysis. Mol Biol Cell 2009; 20: 2030-40.
50. Takino T, Miyamori H, Kawaguchi N et al. Tetraspanin CD63 promotes targeting and lysosomal proteolysis of membrane-type 1 matrix metalloproteinase. Biochem Biophys Res Com 2003; 304: 160-6.
51. Berditchevski F. Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci 2001; 114: 4143-51.
52. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 2005; 6: 801-11.